Perrone, Ronald D.
Malek, Adel M.
Watnick, Terry
Article History
First Online: 11 August 2015
Competing interests
: R.D.P. has received research funding from Sanofi–Genzyme and is a consultant for Otsuka and Vertex. T.W. has received research funding from Otsuka. A.M.M. declares no competing interests.